John E. Baer

1.2k total citations
24 papers, 723 citations indexed

About

John E. Baer is a scholar working on Biochemistry, Molecular Biology and Organic Chemistry. According to data from OpenAlex, John E. Baer has authored 24 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Biochemistry, 5 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in John E. Baer's work include Amino Acid Enzymes and Metabolism (5 papers), Renal function and acid-base balance (3 papers) and Clinical Nutrition and Gastroenterology (2 papers). John E. Baer is often cited by papers focused on Amino Acid Enzymes and Metabolism (5 papers), Renal function and acid-base balance (3 papers) and Clinical Nutrition and Gastroenterology (2 papers). John E. Baer collaborates with scholars based in United States, France and Austria. John E. Baer's co-authors include Karl H. Beyer, Horace F. Russo, S. Spitzer, Christopher B. Jones, Lyman C. Craig, Bernard B. Brodie, R.M. Noll, Sidney Udenfriend, Jack R. Cooper and Carroll T. Clark and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

John E. Baer

24 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John E. Baer United States 14 298 95 77 74 73 24 723
O. Heidenreich Germany 13 187 0.6× 82 0.9× 78 1.0× 91 1.2× 26 0.4× 75 561
Horace F. Russo United States 10 197 0.7× 56 0.6× 47 0.6× 55 0.7× 124 1.7× 19 599
Byron E. Leach United States 15 204 0.7× 57 0.6× 147 1.9× 59 0.8× 59 0.8× 23 795
Karl H. Beyer United States 16 408 1.4× 141 1.5× 142 1.8× 134 1.8× 93 1.3× 65 1.2k
Barbara R. Rennick United States 19 213 0.7× 108 1.1× 70 0.9× 61 0.8× 16 0.2× 42 917
G. Kuschinsky Germany 15 275 0.9× 83 0.9× 77 1.0× 38 0.5× 50 0.7× 99 751
Edward G. Daniels United States 12 203 0.7× 49 0.5× 78 1.0× 47 0.6× 86 1.2× 18 656
M Acara United States 15 242 0.8× 62 0.7× 89 1.2× 69 0.9× 22 0.3× 49 829
Leo R. Goldbaum United States 15 373 1.3× 62 0.7× 51 0.7× 40 0.5× 37 0.5× 29 930
Fritz Lauterbach Germany 15 254 0.9× 41 0.4× 58 0.8× 25 0.3× 23 0.3× 54 606

Countries citing papers authored by John E. Baer

Since Specialization
Citations

This map shows the geographic impact of John E. Baer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Baer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Baer more than expected).

Fields of papers citing papers by John E. Baer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Baer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Baer. The network helps show where John E. Baer may publish in the future.

Co-authorship network of co-authors of John E. Baer

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Baer. A scholar is included among the top collaborators of John E. Baer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Baer. John E. Baer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cella, David, Bernard Escudier, Nizar M. Tannir, et al.. (2016). Quality of life (QoL) in the phase 3 METEOR trial of cabozantinib vs everolimus for advanced renal cell carcinoma (RCC). Annals of Oncology. 27. vi284–vi284. 3 indexed citations
2.
Munn, Samson, et al.. (1986). Ovary volume in young and premenopausal adults: US determination. Work in progress.. Radiology. 159(3). 731–732. 18 indexed citations
3.
Baer, John E., Theodore A. Jacob, & Frank J. Wolf. (1977). Cambendazole and nondrug macromolecules in tissue residues. Journal of Toxicology and Environmental Health. 2(4). 895–903. 12 indexed citations
4.
Duggan, D E, R.M. Noll, John E. Baer, F. Novello, & J. J. Baldwin. (1975). 3,5-Disubstituted 1,2,4-triazoles, a new class of xanthine oxidase inhibitor. Journal of Medicinal Chemistry. 18(9). 900–905. 15 indexed citations
5.
Beyer, Karl H. & John E. Baer. (1975). The Site and Mode of Action of Some Sulfonamide-Derived Diuretics. Medical Clinics of North America. 59(3). 735–750. 18 indexed citations
6.
Baer, John E.. (1972). Role of Drug Metabolism in Drug Research and Development: Basic Considerations. Journal of Pharmaceutical Sciences. 61(10). 1674–1677. 2 indexed citations
7.
Fanelli, George M., et al.. (1972). RENAL EXCRETION AND URICOSURIC PROPERTIES OF HALOFENATE, A HYPOLIPIDEMIC-URICOSURIC AGENT, IN THE CHIMPANZEE. Journal of Pharmacology and Experimental Therapeutics. 180(2). 377–396. 8 indexed citations
8.
Skeggs, Helen R., et al.. (1971). EFFECTS OF THE CHRONIC ADMINISTRATION OF AMILORIDE HYDROCHLORIDE (N-AMIDINO-3,5-DIAMINO-6-CHLOROPYRAZINECARBOXAMIDE HYDROCHLORIDE DIHYDRATE) ON ELECTROLYTE BALANCE IN THE DOG. Journal of Pharmacology and Experimental Therapeutics. 179(2). 438–446. 1 indexed citations
9.
Baer, John E., Christopher B. Jones, S. Spitzer, & Horace F. Russo. (1967). THE POTASSIUM-SPARING AND NATRIURETIC ACTIVITY OF N-AMIDINO-3,5-DIAMINO-6-CHLOROPYRAZINECAR-BOXAMIDE HYDROCHLORIDE DIHYDRATE (AMILORIDE HYDROCHLORIDE). Journal of Pharmacology and Experimental Therapeutics. 157(2). 472–485. 126 indexed citations
10.
Beyer, Karl H. & John E. Baer. (1967). Enzymes, drugs and transport phenomena. PROTOPLASMA. 63(1-3). 112–120. 3 indexed citations
11.
Duggan, D E, John E. Baer, & R.M. Noll. (1965). Membrane adenosinetriphosphatase and cation composition of mammalian erythrocytes. Die Naturwissenschaften. 52(10). 264–264. 13 indexed citations
12.
Beyer, Karl H., et al.. (1965). RENOTROPIC CHARACTERISTICS OF ETHACRYNIC ACID: A PHENOXYACETIC SALURETIC-DIURETIC AGENT. Journal of Pharmacology and Experimental Therapeutics. 147(1). 1–22. 126 indexed citations
13.
Baer, John E., et al.. (1964). A New Class of Diuretic-Saluretic Agents, The  ,  -Unsaturated Ketone Derivatives of Aryloxyacetic Acids. Experimental Biology and Medicine. 115(1). 87–90. 16 indexed citations
14.
Baer, John E., et al.. (1962). EFFECT OF HYDROCHLOROTHIAZIDE ON RENAL ELECTROLYTE GRADIENT IN GLUCOSE DIURESIS AND EXPERIMENTAL DIABETES INSIPIDUS. Journal of Pharmacology and Experimental Therapeutics. 137(3). 319–323. 13 indexed citations
15.
Beyer, Karl H. & John E. Baer. (1961). PHYSIOLOGICAL BASIS FOR THE ACTION OF NEWER DIURETIC AGENTS. Pharmacological Reviews. 13(4). 517–562. 92 indexed citations
16.
Baer, John E., et al.. (1959). THE PHYSIOLOGICAL DISPOSITION OF CHLOROTHIAZIDE (DIURIL) IN THE DOG. Journal of Pharmacology and Experimental Therapeutics. 125(4). 295–302. 56 indexed citations
17.
Baer, John E., et al.. (1958). GASTROINTESTINAL SECRETION AND ABSORPTION OF 3-METHYLAMINOISOCAMPHANE HYDROCHLORIDE (MECAMYLAMINE). Journal of Pharmacology and Experimental Therapeutics. 122(4). 442–448. 3 indexed citations
18.
Baer, John E., et al.. (1954). Acetylation and S-Alkylation of Ethylene Thiourea1. Journal of the American Chemical Society. 76(4). 1162–1164. 8 indexed citations
19.
Udenfriend, Sidney, Jack R. Cooper, Carroll T. Clark, & John E. Baer. (1953). Rate of Turnover of Epinephrine in the Adrenal Medulla. Science. 117(3050). 663–665. 57 indexed citations
20.
Brodie, Bernard B., John E. Baer, & Lyman C. Craig. (1951). METABOLIC PRODUCTS OF THE CINCHONA ALKALOIDS IN HUMAN URINE. Journal of Biological Chemistry. 188(2). 567–581. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O. Heidenreich Breakdown of academic impact, for papers by Horace F. Russo Breakdown of academic impact, for papers by Byron E. Leach Breakdown of academic impact, for papers by Karl H. Beyer Breakdown of academic impact, for papers by Barbara R. Rennick Breakdown of academic impact, for papers by G. Kuschinsky Breakdown of academic impact, for papers by Edward G. Daniels Breakdown of academic impact, for papers by M Acara Breakdown of academic impact, for papers by Leo R. Goldbaum Breakdown of academic impact, for papers by Fritz Lauterbach
Rankless by CCL
2026